EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An antibody–drug conjugate active against antibiotic-resistant Neisseria gonorrhoeae

Hayley Lavender iD, Vincent Oliver iD, Daniel Lucy, Timothy A Barendt, Ann E Jerse iD, Christoph M Tang iD

Proceedings of the National Academy of Sciences · 04.08.2026 · 123 (31)

DOI: 10.1073/pnas.2534217123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 28.07.2026. Verfasst von Hayley Lavender und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Immunoconjugates, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust (WT), ¿¿¿¿ | John Fell Fund, University of Oxford (John Fell OUP Research Fund), Rosetrees Trust (Rosetrees).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neisseria gonorrhoeae is the causative agent of gonorrhea, a sexually transmitted infection which is rising in incidence, with increasing drug-resistant strains posing a significant public health threat. To address the urgent need for novel therapies, we developed an antibody–drug conjugate (ADC) that targets this important human pathogen. We utilized Tridecaptin A 1, a potent antimicrobial peptide (AMP) against Gram-negative bacteria that exhibits significant toxicity against human cells, limiting its development for clinical use. By conjugating the Tridecaptin A 1 analogue, Oct-TriA 1 to a monoclonal antibody (mAb) that specifically targets gonococcal MtrE, the outer membrane component of a drug efflux pump that is upregulated in resistant strains, we aim to selectively deliver the AMP to the gonococcus. However, Oct-TriA 1 was not bactericidal when directly conjugated to mAb. To circumvent this, we exploited an immune evasion mechanism employed by the gonococcus by introducing a linker between Oct-TriA 1 and the mAb which is specifically cleaved by the IgA protease (IgAP) secreted by the gonococcus; the IgAP inactivates human IgA. This ADC has no detectable toxicity for relevant human cells, kills the gonococcus in an MtrE- and IgAP-dependent manner, and is active against a strain which is resistant to first line agents. This modular ADC platform could be extended to other bacterial pathogens which employ proteases to evade immune killing, offering a strategy in the fight against antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeImmunoconjugatesAnti-Bacterial AgentsDrug Resistance, BacterialAntimicrobial PeptidesHumansAntibodies, MonoclonalGonorrheaBacterial ProteinsMicrobial Sensitivity TestsBacterial Outer Membrane Proteins

Stichwörter der Autor:innen

IgA proteaseNeisseria gonorrhoeaeantibody–drug conjugateantimicrobial peptideantimicrobial resistance

Substanzen

ImmunoconjugatesAnti-Bacterial AgentsAntibodies, MonoclonalBacterial ProteinsAntimicrobial PeptidesMtrE protein, Neisseria gonorrhoeaeBacterial Outer Membrane Proteins

Autor:innen und Institutionen

  • Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
  • The Department of Clinical Infection, Microbiology, and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 7BE, United Kingdom.
  • Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817.
  • Department of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • School of Chemistry, University of Birmingham, Birmingham B15 2TT, United Kingdom.
  • Department of Microbiology and Immunology, Uniformed Services, University of the Health Sciences, Bethesda, MD 20814.

ORCID-Profile: Hayley Lavender, Vincent Oliver, Ann E Jerse, Christoph M Tang

Förderung

  • Wellcome Trust (WT)
  • ¿¿¿¿ | John Fell Fund, University of Oxford (John Fell OUP Research Fund)
  • Rosetrees Trust (Rosetrees)

Zitieren

APA

Lavender, H., Oliver, V., Lucy, D., Barendt, T. A., Jerse, A. E., & Tang, C. M. (2026). An antibody–drug conjugate active against antibiotic-resistant Neisseria gonorrhoeae. Proceedings of the National Academy of Sciences, 123(31). https://doi.org/10.1073/pnas.2534217123

Vancouver

Lavender H, Oliver V, Lucy D, Barendt TA, Jerse AE, Tang CM. An antibody–drug conjugate active against antibiotic-resistant Neisseria gonorrhoeae. Proceedings of the National Academy of Sciences. 2026;123(31). doi:10.1073/pnas.2534217123

BibTeX
@article{Lavender2026,
  author = {Lavender, Hayley and Oliver, Vincent and Lucy, Daniel and Barendt, Timothy A and Jerse, Ann E and Tang, Christoph M},
  title = {An antibody–drug conjugate active against antibiotic-resistant Neisseria gonorrhoeae},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {31},
  doi = {10.1073/pnas.2534217123}
}
Kostenlos starten →